Ranbaxy receives FDA notice of possible API plant violations

12:38 PM | January 13, 2014 | Natasha Alperowicz

Ranbaxy Laboratories (Gurgaon, India), India's largest drugs maker and member of the Daiichi Sankyo Group (Tokyo), has been notified by the US Food and Drug Administration (FDA) that a recent...